<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Parkinsons Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Parkinsons Dis</journal-id><journal-id journal-id-type="publisher-id">JPD</journal-id><journal-title-group><journal-title>Journal of Parkinson's Disease</journal-title></journal-title-group><issn pub-type="ppub">1877-7171</issn><issn pub-type="epub">1877-718X</issn><issn-l>1877-7171</issn-l><publisher><publisher-name>IOS Press</publisher-name><publisher-loc>Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7990399</article-id><article-id pub-id-type="pmid">33104043</article-id><article-id pub-id-type="publisher-id">JPD202302</article-id><article-id pub-id-type="doi">10.3233/JPD-202302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Genetics of Progressive Supranuclear Palsy: A Review</article-title><alt-title alt-title-type="left-running-head">Y. Wen et al.</alt-title><alt-title alt-title-type="right-running-head">Genetics of Progressive Supranuclear Palsy</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wen</surname><given-names>Yafei</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yafang</given-names></name><xref ref-type="aff" rid="aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Jiao</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff3">c</xref><xref ref-type="aff" rid="aff4">d</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff3">c</xref><xref ref-type="aff" rid="aff4">d</xref><xref ref-type="aff" rid="aff5">e</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="aff1">
<label>a</label>Department of Neurology, Xiangya Hospital, <institution>Central South University</institution>, Changsha, Hunan, <country>PR China</country></aff><aff id="aff2">
<label>b</label>Department of Geriatrics Neurology, Xiangya Hospital, <institution>Central South University</institution>, Changsha, Hunan, <country>PR China</country></aff><aff id="aff3">
<label>c</label>National Clinical Research Center for Geriatric Disorders, <institution>Central South University</institution>, Changsha, Hunan, <country>PR China</country></aff><aff id="aff4">
<label>d</label>Key Laboratory of Hunan Province in Neurodegenerative Disorders, <institution>Central South University</institution>, Changsha, Hunan, <country>PR China</country></aff><aff id="aff5">
<label>e</label>Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Changsha, Hunan, <country>PR China</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Lu Shen and Bin Jiao, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, PR China. Tel.: +86 731 89753041; E-mails: <email>shenlu@csu.edu.cn</email>. (Lu Shen) and <email>jbin0911@163.com</email>. (Bin Jiao)
</corresp></author-notes><pub-date date-type="preprint" publication-format="electronic"><day>21</day><month>10</month><year>2020</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>2</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><volume>11</volume><issue>1</issue><fpage>93</fpage><lpage>105</lpage><history><date date-type="accepted"><day>26</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 &#x02013; IOS Press. All rights reserved</copyright-statement><copyright-year>2021</copyright-year><license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License</ext-link>, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Progressive supranuclear palsy (PSP) is an atypical parkinsonism with prominent 4R-tau neuropathology, and the classical clinical phenotype is characterized by vertical supranuclear gaze palsy, unprovoked falls, akinetic-rigid syndrome and cognitive decline. Though PSP is generally regarded as sporadic, there is increasing evidence suggesting that a series of common and rare genetic variants impact on sporadic and familial forms of PSP. To date, more than 10 genes have been reported to show a potential association with PSP. Among these genes, the microtubule-associated protein tau (<italic>MAPT</italic>) is the risk locus with the strongest effect size on sporadic PSP in the case-control genome-wide association studies (GWAS). Additionally, <italic>MAPT</italic> mutations are the most common cause of familial PSP while the leucine-rich repeat kinase 2 (<italic>LRRK2</italic>) is a rare monogenic cause of PSP, and several other gene mutations may mimic the PSP phenotype, like the dynactin subunit 1 (<italic>DCTN1</italic>). In total, 15 <italic>MAPT</italic> mutations have been identified in cases with PSP, and the mean age at onset is much earlier than in cases carrying <italic>LRRK2</italic> or <italic>DCTN1</italic> mutations. GWAS have further identified several risk loci of PSP, proposing molecular pathways related to PSP. The present review focused on genetic studies on PSP and summarized genetic factors of PSP, which may help to elucidate the underlying pathogenesis and provide new perspectives for therapeutic strategies.</p></abstract><kwd-group><label>Keywords</label><kwd>Progressive supranuclear palsy</kwd><kwd>genetics</kwd><kwd>microtubule-associated protein 
tau</kwd><kwd>haplotype</kwd><kwd>mutations</kwd><kwd>variants</kwd><kwd>genome-wide association study</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><title>INTRODUCTION</title><p>Progressive supranuclear palsy (PSP), a rare neurodegenerative disorder with a prevalence of approximately 5&#x02013;7 per 100000 [<xref rid="ref001" ref-type="bibr">1</xref>], is traditionally considered to be one of the most common atypical parkinsonian syndromes and increasingly recognized to involve a range of motor, behaviour and language abnormalities [<xref rid="ref002" ref-type="bibr">2</xref>]. PSP is clinically heterogeneous and presents as different phenotypes [<xref rid="ref003" ref-type="bibr">3, 4</xref>], among which the most classic phenotype is Richardson&#x02019;s syndrome (PSP-RS, also known as Steele&#x02013;Richardson&#x02013;Olszewski syndrome), which was first described as a clinicopathological entity in 1964 [<xref rid="ref005" ref-type="bibr">5, 6</xref>]. New clinical diagnostic criteria of PSP (MDS-PSP) were published in 2017 [<xref rid="ref007" ref-type="bibr">7</xref>], improving the sensitivity of PSP, in particular the variant PSP clinical presentations [<xref rid="ref008" ref-type="bibr">8</xref>], and proposing four degrees of diagnostic certainty, namely, definite PSP, probable PSP, possible PSP and suggestive of PSP [<xref rid="ref007" ref-type="bibr">7</xref>].</p><p>The pathological features of PSP are a predominance of 4-repeat (4R) tau inclusions in the form of neurofibrillary tangles, neuropil threads, tufted astrocytes and oligodendroglial coiled bodies in basal ganglia, diencephalon and brainstem, mainly affecting the globus pallidus, subthalamic nucleus and substantia nigra, in addition to neuronal loss and gliosis [<xref rid="ref009" ref-type="bibr">9, 10</xref>]. PSP is the most common primary 4R-tauopathy, and the neuropathological 4R-tau begins to abnormally accumulate during the presymptomatic phase [<xref rid="ref002" ref-type="bibr">2</xref>]. The localization of tau pathology is a major drive of clinical heterogeneity [<xref rid="ref004" ref-type="bibr">4</xref>], and the distribution and severity of tau pathology vary in different clinical phenotypes, suggesting the significance of further studies into the pathological processes related to PSP [<xref rid="ref011" ref-type="bibr">11, 12</xref>].</p><p>Although PSP is generally recognized as a sporadic syndrome, there are familial forms of PSP [<xref rid="ref013" ref-type="bibr">13&#x02013;15</xref>] and few pedigrees with PSP-like phenotypes [<xref rid="ref016" ref-type="bibr">16, 17</xref>], and a pattern of autosomal dominant inheritance has been proposed [<xref rid="ref014" ref-type="bibr">14, 15</xref>]. A case-control study has observed more first-degree relatives with parkinsonism or dementia in patients with PSP than in controls, demonstrating familial aggregation in PSP [<xref rid="ref018" ref-type="bibr">18</xref>]. In contrast, genome-wide association studies (GWAS) in large cohorts over the past few years have identified several loci significantly associated with PSP [<xref rid="ref019" ref-type="bibr">19&#x02013;22</xref>], prompting studies on PSP genetics. Though a series of questions remain to be solved, genetics play an important role in PSP. This review focused on genetic studies and summarized genetic factors associated with PSP, especially recent additions, aiming to better understand PSP at the genetic level.</p></sec><sec id="sec0010"><title>SINGLE-GENE MUTATIONS ASSOCIATED WITH PSP</title><sec id="sec0015"><title>MAPT in PSP</title><p>The microtubule-associated protein tau (<italic>MAPT</italic>) gene, encoding the tau protein, is located on chromosome 17q21.31 and consists of 16 exons [<xref rid="ref023" ref-type="bibr">23</xref>]. Among the exons, exons E0 and 14 are non-coding, and exons 4a, 6 and 8 are not transcribed or expressed in human brain [<xref rid="ref024" ref-type="bibr">24</xref>]. Alternative splicing of exon 10 produces two major isoforms of tau protein, namely 4R-tau and 3R-tau, with four and three microtubule binding repeats, respectively. In adult human brain, the ratio of 4R to 3R is roughly equal to 1 [<xref rid="ref025" ref-type="bibr">25</xref>]. Zero, one or two N-terminal inserts result from alternative splicing of exon 2 or exon 2 and 3 together, and each N-terminal insert contains 29 amino acids. Therefore, there are six major tau isoforms with different lengths in the human brain (<xref ref-type="fig" rid="jpd-11-jpd202302-g001">Fig.&#x000a0;1</xref>) [<xref rid="ref024" ref-type="bibr">24</xref>]. <italic>MAPT</italic> mutations were first reported in families of frontotemporal dementia (FTD) and parkinsonism linked to chromosome 17 (FTDP-17) in 1998 [<xref rid="ref026" ref-type="bibr">26</xref>]. Since then, more than 60 mutations in <italic>MAPT</italic> have been identified, mostly characterized by behavioural changes and/or clinical parkinsonism [<xref rid="ref027" ref-type="bibr">27</xref>]. <italic>MAPT</italic> is involved in a series of neurodegenerative disorders [<xref rid="ref028" ref-type="bibr">28</xref>] and the case-control GWAS of PSP has identified that <italic>MAPT</italic> is the risk locus with the strongest effect size [<xref rid="ref019" ref-type="bibr">19</xref>].</p><fig id="jpd-11-jpd202302-g001" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Six isoforms of protein tau and 15 mutations of <italic>MAPT</italic> associated with PSP.</p></caption><graphic xlink:href="jpd-11-jpd202302-g001"/></fig><sec id="sec0020"><title>MAPT haplotypes and PSP</title><p>A case-control study first observed that the homozygous A0 alleles containing 11 TG repeats in intron 9 of <italic>MAPT</italic> are overrepresented in PSP, identifying a dinucleotide repeat polymorphism linked with PSP and providing direct genetic evidence for the association between PSP and <italic>MAPT</italic> [<xref rid="ref029" ref-type="bibr">29</xref>], which has been validated by several groups [<xref rid="ref030" ref-type="bibr">30&#x02013;32</xref>]. Baker et al. [<xref rid="ref033" ref-type="bibr">33</xref>] subsequently found that the polymorphic dinucleotide marker is inherited in complete disequilibrium linkage with other eight common single nucleotide polymorphisms (SNPs). These researchers initially described two extended haplotypes (called H1 and H2) covering the entire <italic>MAPT</italic> and observed that haplotype H1 with 238 bp in intron 9 is overrepresented in PSP patients compared to controls. Various studies on Caucasian populations have emphasized the significant association between <italic>MAPT</italic> haplotype H1 and PSP [<xref rid="ref034" ref-type="bibr">34, 35</xref>]. A GWAS directly compared rs8070723 to H1/H2 as a proxy and observed that the odds ratio (OR) for PSP in H1/H1 carriers in the GWAS is 5.46 (<italic>p</italic>&#x0200a;=&#x0200a;1.5&#x000d7;10<sup>&#x02013;116</sup>) [<xref rid="ref019" ref-type="bibr">19</xref>], and the GWAS suggested that the H2 haplotype had a protective role [<xref rid="ref036" ref-type="bibr">36</xref>].</p><p>The structure of the H1 haplotype has been explored, and over 20 common subhaplotypes have been identified. Among which, <italic>MAPT</italic> H1c is significantly overrepresented in patients with PSP and in patients with corticobasal degeneration (CBD) [<xref rid="ref036" ref-type="bibr">36</xref>] and Alzheimer&#x02019;s disease (AD) [<xref rid="ref037" ref-type="bibr">37</xref>]. H1c increases <italic>MAPT</italic> expression, especially 4R-containing transcripts [<xref rid="ref038" ref-type="bibr">38</xref>], but underlying mechanisms remain unclear. Using a large series of autopsy-confirmed PSP cases, Heckman et al. identified three other <italic>MAPT</italic> H1 subhaplotypes associated with PSP, namely H1g, H1d and H1o, and they also proposed that several subhaplotypes may play roles in the severity of tau pathology in PSP [<xref rid="ref039" ref-type="bibr">39</xref>], further advancing the understanding of the H1 haplotype.</p></sec><sec id="sec0025"><title>MAPT mutations and PSP</title><p>The frequency of PSP cases carrying <italic>MAPT</italic> mutations is various with a range from 0.6% to 14.3% [<xref rid="ref016" ref-type="bibr">16, 18, 40, 41</xref>]. In total, 15 different mutations of <italic>MAPT</italic> have been described in cases presenting as PSP (clinical or neuropathological diagnosis), as shown in <xref rid="jpd-11-jpd202302-t001" ref-type="table">Table&#x000a0;1</xref> and <xref ref-type="fig" rid="jpd-11-jpd202302-g001">Fig.&#x000a0;1</xref>. Except for the R5L mutation in exon1, the V363A mutation in exon12, and the R406W mutation in exon13, other causative mutations exist in exon 10 and its splicing regions, resulting in an increased ratio of 4R/3R. The most common <italic>MAPT</italic> mutation causing PSP is located at codon 279, involving 11 cases. The p.K298_H299insQ in exon 10 has been identified in three patients with familial PSP through genetic sequencing of 165 cases with possible tauopathies, and this mutation is the first insertion mutation reported in <italic>MAPT</italic>. Yasuda et al. identified a N279K mutation in a Japanese patient with pallido-nigro-luysian degeneration (PNLD) [<xref rid="ref042" ref-type="bibr">42</xref>], which is pathologically distinctive from typical PSP and is considered a variant of PSP [<xref rid="ref043" ref-type="bibr">43</xref>].</p><table-wrap id="jpd-11-jpd202302-t001" orientation="portrait" position="float"><label>Table 1</label><caption><p><italic>MAPT</italic> mutations causing PSP-like syndrome</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Mutation</td><td rowspan="1" colspan="1">Region</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">No.</td><td rowspan="1" colspan="1">Initial features</td><td rowspan="1" colspan="1">AAO years</td><td rowspan="1" colspan="1">Clinical diagnosis</td><td rowspan="1" colspan="1">Pathological diagnosis</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">R5L</td><td rowspan="1" colspan="1">Ex1</td><td rowspan="1" colspan="1">Poorkaj et al. [<xref rid="ref046" ref-type="bibr">46</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">falls, dysarthria, and micrographia;</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PSP</td></tr><tr><td rowspan="1" colspan="1">N279K</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Yasuda et al. [<xref rid="ref042" ref-type="bibr">42</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">parkinsonism;</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">PNLD<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Delisle et al. [<xref rid="ref047" ref-type="bibr">47</xref>]</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">apathy, memory disorder, parkinsonism;</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">FTDP-17<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">indifference, attention disturbances;</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">FTDP-17<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Soliveri et al. [<xref rid="ref048" ref-type="bibr">48</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">personality and behaviour changes;</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ogaki et al. [<xref rid="ref049" ref-type="bibr">49, 50</xref>]</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">parkinsonism and micrographia;</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">parkinsonism and oscillopsia;</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">parkinsonism;</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">unstable gait and character changes;</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">shuffling gait and bradykinesia;</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">walking difficulty;</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">N279N</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Ogaki et al. [<xref rid="ref049" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">parkinsonism;</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">L284R</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Rohrer et al. [<xref rid="ref051" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">personality change and falls;</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">S285R</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Ogaki et al. [<xref rid="ref049" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">speaking and breathing difficulty;</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Fujioka et al. [<xref rid="ref014" ref-type="bibr">14</xref>]</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">dystonia and supranuclear gaze palsy;</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP-AD</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">gait changes and bradykinesia;</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP</td></tr><tr><td rowspan="1" colspan="1"><italic>&#x00394;</italic>N296</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Pastor et al. [<xref rid="ref045" ref-type="bibr">45</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">speaking and memory problems;</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">Atypical PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Rossi et al. [<xref rid="ref044" ref-type="bibr">44</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">antecollis, dysarthria and fall;</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">PSP-like<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">K298_H299insQ</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Nakayama et al. [<xref rid="ref041" ref-type="bibr">41</xref>]</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">neck stiffness and postural instability;</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">gait disturbance;</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">gait disturbance and cognitive decline</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">P301L</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Bird et al. [<xref rid="ref052" ref-type="bibr">52</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">tremor and articulation difficulty;</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">APD<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Kaat et al. [<xref rid="ref018" ref-type="bibr">18</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">G303V</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Ros et al. [<xref rid="ref053" ref-type="bibr">53</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">parkinsonism, falls, micrographia, dysarthria, and ocular motor dysfunction;</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP</td></tr><tr><td rowspan="1" colspan="1">S305S</td><td rowspan="1" colspan="1">Ex10</td><td rowspan="1" colspan="1">Stanford et al. [<xref rid="ref054" ref-type="bibr">54</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">dystonia, dysarthria, falls, bradykinesia;</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP</td></tr><tr><td rowspan="1" colspan="1">IVS10&#x0200a;+&#x0200a;3G&#x0003e;A</td><td rowspan="1" colspan="1">IVS10</td><td rowspan="1" colspan="1">Spina et al. [<xref rid="ref055" ref-type="bibr">55</xref>]</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">dizziness and neck stiffness;</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">Atypical PSP<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">dizziness and neck stiffness;</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">Atypical PSP<sup>f</sup></td><td rowspan="1" colspan="1">tauopathy</td></tr><tr><td rowspan="1" colspan="1">IVS10&#x0200a;+&#x0200a;14C&#x0003e;T</td><td rowspan="1" colspan="1">IVS10</td><td rowspan="1" colspan="1">Omoto et al. [<xref rid="ref056" ref-type="bibr">56</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">clumsiness, tremor and apathy;</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">Perry syndrome<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1">IVS10&#x0200a;+&#x0200a;16C&#x0003e;T</td><td rowspan="1" colspan="1">IVS10</td><td rowspan="1" colspan="1">Morris et al. [<xref rid="ref057" ref-type="bibr">57</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">fatigue, micrographia, and withdrawal;</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">tauopathy</td></tr><tr><td rowspan="1" colspan="1">V363A</td><td rowspan="1" colspan="1">Ex12</td><td rowspan="1" colspan="1">Rossi et al. [<xref rid="ref058" ref-type="bibr">58</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">diplopia, falls and bradykinesia;</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">PSP<sup>f</sup></td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">R406W</td><td rowspan="1" colspan="1">Ex13</td><td rowspan="1" colspan="1">Ygland et al. [<xref rid="ref017" ref-type="bibr">17</xref>]</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">personality change;</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">AD<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">dyscalculia, social withdrawal, apathy;</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">AD<sup>f</sup></td><td rowspan="1" colspan="1">PSP-like</td></tr></tbody></table><table-wrap-foot><p>No., number; AAO, age at onset; NA, not available; PSP, progressive supranuclear palsy; PNLD, pallido-nigro-luysian degeneration; FTDP-17, frontotemporal dementia and parkinsonism linked to chromosome 17; AD, Alzheimer&#x02019;s disease; PSP-AD, PSP with concomitant AD. &#x0201c;PSP-like&#x0201d; pathology means that tau accumulations exist in brain but do not meet the pathological diagnostic criteria of PSP. The letter &#x0201c;f&#x0201d; in clinical diagnosis indicates the case with a family history of parkinsonism, dementia, or other neurodegenerative diseases.</p></table-wrap-foot></table-wrap><p>The onset of PSP is insidious, presenting with different symptoms, which highlights the clinical heterogeneity and complexity of PSP as well as the necessity of follow-up. The mean age at onset (AAO) in PSP with <italic>MAPT</italic> mutations is approximately 44.8 years (range of 36&#x02013;62 years) with a peak in the early 40s. Two families [<xref rid="ref044" ref-type="bibr">44, 45</xref>] carrying the <italic>&#x00394;</italic>N296 mutation had an earlier age (&#x0003c;40 years) when first PSP-related symptoms occurred compared to cases carrying other mutations. Moreover, Pastor et al. [<xref rid="ref045" ref-type="bibr">45</xref>] identified a patient carrying the homozygous <italic>&#x00394;</italic>N296 mutation, which is the first case carrying a pathogenic homozygous mutation in <italic>MAPT</italic>, resulting in a more severe phenotype compared to heterozygous mutations, the latter causing a milder condition with reduced penetrance.</p><p>Except for the R5L mutation described in a sporadic PSP case, <xref rid="jpd-11-jpd202302-t001" ref-type="table">Table&#x000a0;1</xref> shows that the majority of cases with other <italic>MAPT</italic> mutations have a family history with parkinsonism, dementia, or other neurodegenerative disorders, further supporting the familial aggregation in PSP, which is consistent with the results reported by Kaat et al. [<xref rid="ref018" ref-type="bibr">18</xref>]. This phenomenon indicates the importance to exclude <italic>MAPT</italic> mutations when such a family history exists.</p><p>Recently, Chen et al. observed 2 patients with autopsy-confirmed PSP harboring duplications spanning the entire <italic>MAPT</italic> locus (both copy number&#x0200a;=&#x0200a;3) through genome-wide survey of copy number variants (CNVs) and proposed that <italic>MAPT</italic> duplications may be a genetic cause of PSP, which provides genetic evidence for the hypothesis that CNVs are associated with PSP [<xref rid="ref022" ref-type="bibr">22</xref>] and indicates that there are more potential associations between MAPT and PSP.</p></sec></sec><sec id="sec0030"><title>LRRK2: a very rare monogenic cause of PSP pathology</title><p>Leucine-rich repeat kinase 2 (<italic>LRRK2</italic>) is considered as one of the most common genetic causes of Parkinson&#x02019;s disease (PD), and genetic evidence has shown more than 5 <italic>LRRK2</italic> mutations linked with both familial and sporadic PD [<xref rid="ref059" ref-type="bibr">59&#x02013;61</xref>]. Although several studies have detected negative results when screening <italic>LRRK2</italic> in PSP cohorts [<xref rid="ref062" ref-type="bibr">62&#x02013;65</xref>], 5 mutations have been identified in patients presenting a PSP phenotype (<xref rid="jpd-11-jpd202302-t002" ref-type="table">Table&#x000a0;2</xref>). A recent study identified that common variation at the <italic>LRRK2</italic> locus is a genetic determinant of PSP survival (Jabbari et al. unpublished data), adding further evidence for the association between <italic>LRRK2</italic> and PSP.</p><table-wrap id="jpd-11-jpd202302-t002" orientation="portrait" position="float"><label>Table 2</label><caption><p><italic>LRRK2</italic> mutations in cases with PSP phenotype</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="justify" span="1"/></colgroup><thead><tr><td rowspan="1" colspan="1">Mutation</td><td rowspan="1" colspan="1">R1441C</td><td rowspan="1" colspan="1">R1441H</td><td rowspan="1" colspan="1">G2019S</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">T2310M</td><td rowspan="1" colspan="1">A1413T</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">cDNA</td><td rowspan="1" colspan="1">c.4321C&#x0200a;&#x0003e;&#x0200a;T</td><td rowspan="1" colspan="1">c.4322G&#x0200a;&#x0003e;&#x0200a;A</td><td rowspan="1" colspan="1">c. 6055G&#x0200a;&#x0003e;&#x0200a;A</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.6928 <italic>C</italic>&#x0200a;&#x0003e;&#x0200a;T</td><td rowspan="1" colspan="1">c.4237 <italic>G</italic>&#x0200a;&#x0003e;&#x0200a;A</td></tr><tr><td rowspan="1" colspan="1">Region</td><td rowspan="1" colspan="1">Exon 31</td><td rowspan="1" colspan="1">Exon 31</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Exon 41</td><td rowspan="1" colspan="1">Exon 47</td><td rowspan="1" colspan="1">Exon 30</td></tr><tr><td rowspan="1" colspan="1">Year of publication</td><td rowspan="1" colspan="1">2004 [<xref rid="ref066" ref-type="bibr">66, 73</xref>]</td><td rowspan="1" colspan="1">2006 [<xref rid="ref067" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">2006 [<xref rid="ref068" ref-type="bibr">68</xref>]</td><td rowspan="1" colspan="1">2011 [<xref rid="ref069" ref-type="bibr">69</xref>]</td><td rowspan="1" colspan="1">2017 [<xref rid="ref059" ref-type="bibr">59</xref>]</td><td rowspan="1" colspan="1">2019 [<xref rid="ref070" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">2015 [<xref rid="ref072" ref-type="bibr">72</xref>]</td><td rowspan="1" colspan="1">2017 [<xref rid="ref059" ref-type="bibr">59</xref>]</td></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Male</td></tr><tr><td rowspan="1" colspan="1">Nationality</td><td rowspan="1" colspan="1">American</td><td rowspan="1" colspan="1">Greek</td><td rowspan="1" colspan="1">English</td><td rowspan="1" colspan="1">Italian</td><td rowspan="1" colspan="1">white Jewish</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Korean</td><td rowspan="1" colspan="1">Filipino</td></tr><tr><td rowspan="1" colspan="1">Familial history</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">AAO, y</td><td rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">80s</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">72</td></tr><tr><td rowspan="1" colspan="1">Duration of disease, y</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">7</td></tr><tr><td rowspan="1" colspan="1">Clinical features</td><td rowspan="1" colspan="1">parkinsonism and supranuclear gaze palsy</td><td rowspan="1" colspan="1">parkinsonism, bulbar dysfunction and dementia</td><td rowspan="1" colspan="1">parkinsonism</td><td rowspan="1" colspan="1">tremor and micrographia</td><td rowspan="1" colspan="1">bulbar dysfunction, tremor, vertical gaze palsy and retrocollis</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">memory problems, falls and apraxia of eyelid opening</td></tr><tr><td rowspan="1" colspan="1">Response to L-dopa</td><td rowspan="1" colspan="1">Good</td><td rowspan="1" colspan="1">Good</td><td rowspan="1" colspan="1">Minimal</td><td rowspan="1" colspan="1">poor</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Poor</td></tr><tr><td rowspan="1" colspan="1">MAPT haplotype</td><td rowspan="1" colspan="1">H1/H1</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">H1/H1</td><td rowspan="1" colspan="1">H1/H1</td><td rowspan="1" colspan="1">H1/H1</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">H1/H1</td></tr><tr><td rowspan="1" colspan="1">Clinical diagnosis</td><td rowspan="1" colspan="1">PD</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PD</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PD</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PSP</td></tr><tr><td rowspan="1" colspan="1">Pathology</td><td rowspan="1" colspan="1">Parkinsonism due to tauopathy</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">PSP and early AD</td><td rowspan="1" colspan="1">PSP and early AD</td><td rowspan="1" colspan="1">PSP and early AD</td><td rowspan="1" colspan="1">AD and PSP</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">PSP-like</td></tr></tbody></table><table-wrap-foot><p>PSP, progressive supranuclear palsy; AD, Alzheimer&#x02019;s disease; AAO, age at onset; NA, not available; &#x0201c;+&#x0201d;, present; &#x0201c;&#x02013;&#x0201d;, absent.</p></table-wrap-foot></table-wrap><p>The R1441C mutation has been reported in a large kindred named family D with pleomorphic pathology and within 10 affected members who are clinically characterized by parkinsonism, but only one member has pathological changes similar to PSP. Thus, the researchers speculated that <italic>LRRK2</italic> might contribute to tauopathy in addition to synucleinopathy [<xref rid="ref066" ref-type="bibr">66</xref>]. The R1441H mutation has been identified in a patient originally diagnosed as typical PD but transiting to PSP 8 years later. This unusual case indicates that the R1441H is involved in the PSP-Parkinsonism (PSP-P) [<xref rid="ref067" ref-type="bibr">67</xref>], but the involvement of environmental factors in this process remains unknown. G2019S has been observed in 4 cases with PSP from different studies [<xref rid="ref059" ref-type="bibr">59, 68&#x02013;70</xref>], and functional <italic>in vitro</italic> studies have observed that the G2019S mutation increases kinase activity, potentially explaining how <italic>LRRK2</italic> causes neurodegeneration [<xref rid="ref071" ref-type="bibr">71</xref>]. Trinh et al. [<xref rid="ref072" ref-type="bibr">72</xref>] observed the T2310M mutation in a patient with PSP when sequencing <italic>LRRK2</italic>, and they also identified 27 other rare nonsynonymous variants in the cohorts. A novel p.A1413T mutation has been identified in a case-control study containing 1039 PSP and 145 CBD patients, and this mutation has been predicted to be &#x0201c;disease damaging&#x0201d; by several <italic>in silico</italic> predictive algorithms [<xref rid="ref059" ref-type="bibr">59</xref>].</p><p>Therefore, we conclude that the <italic>LRRK2</italic> gene is a rare pathologic gene associated with PSP [<xref rid="ref059" ref-type="bibr">59</xref>] despite inconsistent results in some studies. More association studies in larger cohorts and various populations are needed to further elucidate how these <italic>LRRK2</italic> mutations lead to tauopathy and whether other mutations increase the risk for PSP.</p></sec><sec id="sec0035"><title>Single-gene mutations in cases mimicking PSP</title><sec id="sec0040"><title>DCTN1 mutations in cases as PSP look-alike syndromes</title><p>Dynactin subunit 1 (<italic>DCTN1</italic>), which encodes p150<sup>glued</sup>, is the largest subunit of dynactin complex, and it is involved in microtubule binding and molecular transport [<xref rid="ref074" ref-type="bibr">74</xref>]. <italic>DCTN1</italic> mutations have been identified in families with motor neuron disease [<xref rid="ref075" ref-type="bibr">75</xref>] and Perry syndrome [<xref rid="ref076" ref-type="bibr">76</xref>], which is a rare autosomal dominant neurodegenerative disease. Unlike tauopathy in PSP, the underlying pathology in <italic>DCTN1</italic> mutation carriers is transactive response DNA-binding protein of 43 kDa (TDP-43) proteinopathy [<xref rid="ref077" ref-type="bibr">77</xref>]. To advance the understanding of clinical phenotype spectrum related to <italic>DCTN1</italic> mutations, we summarized 3 <italic>DCTN1</italic> mutations reported in patients with a PSP look-alike syndrome (<xref rid="jpd-11-jpd202302-t003" ref-type="table">Table&#x000a0;3</xref>). However, the p.R1261Q mutation in one PSP-PS case and the p.L896V mutation in one PSP-FTD case both detected by Yabe et al. [<xref rid="ref016" ref-type="bibr">16</xref>] are not included in <xref rid="jpd-11-jpd202302-t003" ref-type="table">Table&#x000a0;3</xref> due to lack of clinical data.</p><table-wrap id="jpd-11-jpd202302-t003" orientation="portrait" position="float"><label>Table 3</label><caption><p><italic>DCTN1</italic> mutations associated with PSP look-alike syndromes</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="justify" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Mutation</td><td rowspan="1" colspan="1">G71E</td><td colspan="2" align="left" rowspan="1">K56R</td><td rowspan="1" colspan="1">F52L</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">cDNA</td><td rowspan="1" colspan="1">c.212G&#x0200a;&#x0003e;&#x0200a;A</td><td colspan="2" align="left" rowspan="1">c.167A&#x0200a;&#x0003e;&#x0200a;G</td><td rowspan="1" colspan="1">c.156T&#x0200a;&#x0003e;&#x0200a;G</td></tr><tr><td rowspan="1" colspan="1">Region</td><td rowspan="1" colspan="1">Exon 2</td><td colspan="2" align="left" rowspan="1">Exon 2</td><td rowspan="1" colspan="1">Exon 2</td></tr><tr><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Caroppo et al. [<xref rid="ref078" ref-type="bibr">78</xref>]</td><td colspan="2" align="left" rowspan="1">Gustavsson et al. [<xref rid="ref079" ref-type="bibr">79</xref>]</td><td rowspan="1" colspan="1">Honda et al. [<xref rid="ref080" ref-type="bibr">80</xref>]</td></tr><tr><td rowspan="1" colspan="1">Number</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Female</td></tr><tr><td rowspan="1" colspan="1">Nationality</td><td rowspan="1" colspan="1">French</td><td rowspan="1" colspan="1">Chinese-Canadian</td><td rowspan="1" colspan="1">Chinese</td><td rowspan="1" colspan="1">Japanese</td></tr><tr><td rowspan="1" colspan="1">Familial history</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">AAO, y</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">48</td></tr><tr><td rowspan="1" colspan="1">Duration of disease, y</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">26</td></tr><tr><td rowspan="1" colspan="1">Clinical features</td><td rowspan="1" colspan="1">parkinsonism, frontal signs and oculomotor disorders</td><td rowspan="1" colspan="1">parkinsonism and oculomotor disorders</td><td rowspan="1" colspan="1">parkinsonism and memory decline</td><td rowspan="1" colspan="1">parkinsonism, central hypoventilation</td></tr><tr><td rowspan="1" colspan="1">Imaging findings</td><td rowspan="1" colspan="1">mild mid brain and frontal atrophy</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">diffuse cortical atrophy</td><td rowspan="1" colspan="1">frontal atrophy</td></tr><tr><td rowspan="1" colspan="1">Clinical diagnosis</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">PSP</td><td rowspan="1" colspan="1">Perry syndrome</td></tr><tr><td rowspan="1" colspan="1">Pathology</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">PSP-like</td></tr></tbody></table><table-wrap-foot><p>PSP, progressive supranuclear palsy; AAO, age at onset; NA, not available; &#x0201c;+&#x0201d;, present.</p></table-wrap-foot></table-wrap><p>
<xref rid="jpd-11-jpd202302-t003" ref-type="table">Table&#x000a0;3</xref> shows that the mean AAO among these cases is 56.3 years with a large range of disease duration. All patients presented parkinsonism as a major clinical feature, and symmetrical frontal atrophy was obvious in more than half of the cases. <italic>DCTN1</italic> mutations play a role in susceptibility to PSP. Due to the low frequency and limited knowledge, however, the underlying mechanism between <italic>DCTN1</italic> and tauopathy remains unclear and needs further validation.</p></sec><sec id="sec0045"><title>Other genes and PSP look-alike syndromes</title><p>As genetic studies on neurodegenerative disorders develop, more genes have shown potential links with PSP. A new series of gene mutations or polymorphisms have been identified in patients with a PSP look-alike phenotype, including but not limited to the <italic>NPC1</italic> gene [<xref rid="ref081" ref-type="bibr">81, 82</xref>], the <italic>C9orf72</italic> gene [<xref rid="ref040" ref-type="bibr">40, 83</xref>], the parkin gene (<italic>PARK2</italic>) [<xref rid="ref084" ref-type="bibr">84&#x02013;86</xref>], the transactivation response element DNA-binding protein gene (<italic>TARDBP</italic>) [<xref rid="ref087" ref-type="bibr">87, 88</xref>], the progranulin gene (<italic>GRN</italic>) [<xref rid="ref016" ref-type="bibr">16, 89</xref>], the TANK-binding kinase 1 gene (<italic>TBK1</italic>) [<xref rid="ref090" ref-type="bibr">90</xref>], and the bassoon gene (<italic>BSN</italic>) [<xref rid="ref016" ref-type="bibr">16</xref>] (<xref rid="jpd-11-jpd202302-t004" ref-type="table">Table&#x000a0;4</xref>). Some of these genes have been considered as causative genes in certain neurodegenerative diseases [<xref rid="ref091" ref-type="bibr">91&#x02013;94</xref>]. Considering the wide phenotype spectrum of monogenic mutations and the overlap among clinical features of neurodegenerative diseases [<xref rid="ref095" ref-type="bibr">95</xref>], there may be common mechanisms and pathways in the pathogenesis of parkinsonian syndromes.</p><table-wrap id="jpd-11-jpd202302-t004" orientation="portrait" position="float"><label>Table 4</label><caption><p>Single-genes associated with PSP look-alike syndromes</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="left" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Genes</td><td rowspan="1" colspan="1">Mutations</td><td rowspan="1" colspan="1">Number</td><td rowspan="1" colspan="1">Authors and year</td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>DCTN1</italic></td><td rowspan="1" colspan="1">G71E</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Caroppo et al. 2014 [<xref rid="ref078" ref-type="bibr">78</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">K56R</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Gustavsson et al. 2016 [<xref rid="ref079" ref-type="bibr">79</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">F52L</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Honda et al. 2018 [<xref rid="ref080" ref-type="bibr">80</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L896V</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R1261Q</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>NPC1</italic></td><td rowspan="1" colspan="1">K576R</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Godeiro-Junior et al. 2006 [<xref rid="ref081" ref-type="bibr">81</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P1007A and F1221fsX20*</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Godeiro-Junior et al. 2006 [<xref rid="ref081" ref-type="bibr">81</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">F284LfsX26</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Cupidi et al. 2017 [<xref rid="ref082" ref-type="bibr">82</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>C9orf72</italic></td><td rowspan="1" colspan="1">&#x0003e;60 repeat units</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Lesage et al. 2013 [<xref rid="ref083" ref-type="bibr">83</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Leber et al. 2013 [<xref rid="ref040" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003e;50 repeat units</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Wilke et al. 2016 [<xref rid="ref096" ref-type="bibr">96</xref>]</td></tr><tr><td rowspan="1" colspan="1">PARK2</td><td rowspan="1" colspan="1">C212Y</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Morales et al. 2002 [<xref rid="ref084" ref-type="bibr">84</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sanchez et al. 2002 [<xref rid="ref085" ref-type="bibr">85</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>TARDBP</italic></td><td rowspan="1" colspan="1">A382T</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Cannas et al. 2014 [<xref rid="ref087" ref-type="bibr">87</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">I239V</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2016 [<xref rid="ref088" ref-type="bibr">88</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>GRN</italic></td><td rowspan="1" colspan="1">Thr272fs</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Tremolizzo et al. 2011 [<xref rid="ref089" ref-type="bibr">89</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">N118del</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">V500I</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">C221S</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>TBK1</italic></td><td rowspan="1" colspan="1">E643del</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Wilke et al. 2018 [<xref rid="ref090" ref-type="bibr">90</xref>]</td></tr><tr><td rowspan="1" colspan="1"><italic>BSN</italic></td><td rowspan="1" colspan="1">P2855L</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R3146C</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">G3627V</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P3866A</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">Yabe et al. 2018 [<xref rid="ref016" ref-type="bibr">16</xref>]</td></tr></tbody></table><table-wrap-foot><p>*The case carried a compound heterozygous mutation (P1007A and F1221fsX20).</p></table-wrap-foot></table-wrap><p>In summary, cases carrying <italic>MAPT</italic> mutations have an earlier AAO (mean: 44.8 years), and the initial features are variable, mainly presenting parkinsonism, unstable walking and frontal cognitive/behavioural symptoms. In addition, a positive family history exists in most cases. The AAOs in patients with <italic>LRRK2</italic> mutations are much older (mean: 72.3 years), and the main clinical presentation is parkinsonism with a baseline clinical diagnosis of PD in some cases. Similarly, the typical symptoms in cases carrying <italic>DCTN1</italic> mutations are parkinsonism (mean AAO: 56.3 years) and brain atrophy. The relationships between genes and phenotypes may help clinicians to correctly diagnose. Although the associations between genes and PSP require more validations and investigations, further genetic screening is necessary when <italic>MAPT</italic> mutations are absent, especially in familial cases reminiscent of PSP.</p></sec></sec></sec><sec id="sec0050"><title>COMMON VARIANTS IDENTIFIED THROUGH GENOME-WIDE APPROACHES</title><p>Melquist et al. carried out a pooled genome-wide scan of 500288 SNPs in 2007 and identified chromosome 11p12-p11 as another major risk locus for PSP following the <italic>MAPT</italic> haplotype H1. They further narrowed the locus to rs901746, the top ranked SNP, which mainly encompasses two genes (DNA damage-binding protein 2 (<italic>DDB2</italic>) and lysosomal acid phosphatase 2 (<italic>ACP2</italic>)) [<xref rid="ref097" ref-type="bibr">97</xref>].</p><p>GWAS have identified thousands of genes and SNPs that contribute to complex diseases in humans [<xref rid="ref098" ref-type="bibr">98</xref>] since the first GWAS was published in 2005 [<xref rid="ref099" ref-type="bibr">99</xref>], introducing a new perspective on genetic studies and showing promising values in clinical applications [<xref rid="ref100" ref-type="bibr">100</xref>]. the first large PSP GWAS revealed that <italic>MAPT</italic> rs8070723 and rs242557 are strongly associated with PSP (1.5&#x000d7;10<sup>&#x02013;116</sup> and 4.2&#x000d7;10<sup>&#x02013;70</sup>, respectively), and it uncovered 3 novel risk loci of PSP (shown in <xref rid="jpd-11-jpd202302-t004" ref-type="table">Table&#x000a0;4</xref>) [<xref rid="ref019" ref-type="bibr">19</xref>], highlighting new directions and strategies for PSP studies. Subsequent GWAS consisting of European cohorts identified additional variants (<xref rid="jpd-11-jpd202302-t005" ref-type="table">Table&#x000a0;5</xref>).</p><table-wrap id="jpd-11-jpd202302-t005" orientation="portrait" position="float"><label>Table 5</label><caption><p>Risk loci identified through GWAS</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Chr band</td><td rowspan="1" colspan="1">SNP</td><td rowspan="1" colspan="1">Nearest gene</td><td rowspan="1" colspan="1">OR (95% CI)</td><td rowspan="1" colspan="1">p</td><td rowspan="1" colspan="1">Cohorts</td><td rowspan="1" colspan="1">Method</td><td rowspan="1" colspan="1">Ref.</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">17q21.31</td><td rowspan="1" colspan="1">rs8070723</td><td rowspan="1" colspan="1"><italic>MAPT</italic></td><td rowspan="1" colspan="1">5.46</td><td rowspan="1" colspan="1">1.5&#x000d7;10<sup>&#x02013;116</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(4.72 &#x02013;6.31)</td></tr><tr><td rowspan="1" colspan="1">17q21.31</td><td rowspan="1" colspan="1">rs242557</td><td rowspan="1" colspan="1"><italic>MAPT</italic></td><td rowspan="1" colspan="1">0.51</td><td rowspan="1" colspan="1">4.2&#x000d7;10<sup>&#x02013;70</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.47 &#x02013;0.55)</td></tr><tr><td rowspan="1" colspan="1">1q25.3</td><td rowspan="1" colspan="1">rs1411478</td><td rowspan="1" colspan="1"><italic>STX6</italic></td><td rowspan="1" colspan="1">0.79</td><td rowspan="1" colspan="1">2.3&#x000d7;10<sup>&#x02013;10</sup></td><td rowspan="1" colspan="1">PSP:2165</td><td rowspan="1" colspan="1">Two-stage</td><td rowspan="1" colspan="1">Hoglinger</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.74 &#x02013;0.85)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NC:6807</td><td rowspan="1" colspan="1">GWAS</td><td rowspan="1" colspan="1">et al. [<xref rid="ref019" ref-type="bibr">19</xref>]</td></tr><tr><td rowspan="1" colspan="1">2p11.2</td><td rowspan="1" colspan="1">rs7571971</td><td rowspan="1" colspan="1"><italic>EIF2AK3</italic></td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">3.2&#x000d7;10<sup>&#x02013;13</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.69 &#x02013;0.81)</td></tr><tr><td rowspan="1" colspan="1">3p22.1</td><td rowspan="1" colspan="1">rs1768208</td><td rowspan="1" colspan="1"><italic>MOBP</italic></td><td rowspan="1" colspan="1">0.72</td><td rowspan="1" colspan="1">1.0&#x000d7;10<sup>&#x02013;16</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.67 &#x02013;0.78)</td></tr><tr><td rowspan="1" colspan="1">1q41</td><td rowspan="1" colspan="1">rs6687758</td><td rowspan="1" colspan="1"><italic>DUSP10</italic></td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">1.1&#x000d7;10&#x02013;8</td><td rowspan="1" colspan="1">PSP:2698</td><td rowspan="1" colspan="1">Meta-analysis</td><td rowspan="1" colspan="1">Sanchez-Contreras</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.74&#x02013;0.86)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NC:8019</td><td rowspan="1" colspan="1">of two GWAS</td><td rowspan="1" colspan="1">et al. [<xref rid="ref020" ref-type="bibr">20</xref>]</td></tr><tr><td rowspan="1" colspan="1">12p12.1</td><td rowspan="1" colspan="1">rs11568563</td><td rowspan="1" colspan="1"><italic>SLCO1A2</italic></td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">5.3&#x000d7;10<sup>&#x02013;10</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(0.59&#x02013;0.76)</td></tr><tr><td rowspan="1" colspan="1">6p21.1</td><td rowspan="1" colspan="1">rs35740963</td><td rowspan="1" colspan="1"><italic>RUNX2</italic></td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">1.8&#x000d7;10<sup>&#x02013;8</sup></td><td rowspan="1" colspan="1">PSP:1646</td><td rowspan="1" colspan="1">Joint</td><td rowspan="1" colspan="1">Chen</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(NA)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NC:10662</td><td rowspan="1" colspan="1">GWAS</td><td rowspan="1" colspan="1">et al. [<xref rid="ref021" ref-type="bibr">21</xref>]</td></tr></tbody></table><table-wrap-foot><p>Chr, chromosome; SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval; NA, not available; PSP, progressive supranuclear palsy; Ref., reference; NC, normal controls; GWAS, genome-wide association study; <italic>STX6</italic>, Syntaxin 6; <italic>EIF2AK3</italic>, Eukaryotic translation initiation factor 2 alpha kinase 3; <italic>MOBP</italic>, Myelin-associated oligodendrocyte basic protein; <italic>DUSP10</italic>, Dual specificity phosphatase 10; <italic>SLCO1A2</italic>, Solute carrier organic anion transporter family member 1A2; <italic>TRIM11</italic>, tripartite motif-containing protein 11; <italic>RUNX2</italic>, runt-related transcription factor 2.</p></table-wrap-foot></table-wrap><p>GWAS have not only identified genetic factors likely increasing the risk for PSP but have also identified several molecular pathways contributing to PSP pathogenesis [<xref rid="ref019" ref-type="bibr">19, 101</xref>]. Eukaryotic translation initiation factor 2 alpha kinase 3 (<italic>EIF2AK3</italic>) encodes the pancreatic endoplasmic reticulum kinase (PERK) protein, which is involved in the endoplasmic reticulum unfolded protein response (UPR) [<xref rid="ref102" ref-type="bibr">102</xref>]. Activated UPR is present in regions affected in PSP, and UPR activation is related to tau [<xref rid="ref103" ref-type="bibr">103</xref>]. Furthermore, loss of PERK function due to <italic>EIF2AK3</italic> mutations causes neurodegeneration-like changes, including tau pathology [<xref rid="ref104" ref-type="bibr">104</xref>]. Because tau normally does not traffic through the endoplasmic reticulum, the mechanisms involved in PERK, UPR and tauopathies are unknown [<xref rid="ref019" ref-type="bibr">19</xref>]. Surprisingly, the increased representation of rs1768208 with the minor T-allele in PSP cases is more closely linked with the expression of the <italic>SLC25A38/Appoptosin</italic> gene, though its location is nearer to the myelin-associated oligodendrocyte basic protein (<italic>MOBP</italic>) gene [<xref rid="ref019" ref-type="bibr">19, 105</xref>]. Zhao and his collaborators showed that appoptosin overexpression contributes to tau cleavage via caspase activation, which results in aggregation of insoluble tau, disruption of synaptic structures, and deficits of motor function in tau transgenic mice [<xref rid="ref105" ref-type="bibr">105</xref>], confirming the associations among rs1768208, appoptosin and PSP as well as suggesting a potential diagnostic biomarker for tauopathies.</p></sec><sec id="sec0055"><title>A GENETIC DETERMINANT OF PSP PHENOTYPE</title><p>Jabbari and colleagues carried out a clinical phenotype GWAS through comparing PSP-RS cases to non-RS cases in PSP cohorts, and suggested that rs564309, an intronic variant of the tripartite motif-containing protein 11 gene (<italic>TRIM11</italic>), may be a genetic modifier of clinical phenotype in PSP [<xref rid="ref106" ref-type="bibr">106</xref>]. This is the first clinical phenotype GWAS in PSP and opens up new directions for the roles that genetics play in PSP phenotypes. On the other hand, as previous study has proposed that TRIM11 has a critical role in the clearance of misfolded proteins via ubiquitin proteasome system (UPS) [<xref rid="ref107" ref-type="bibr">107</xref>], Jabbari&#x02019;s study further proves that UPS is involved in tau pathology, which may provide a target for PSP therapy [<xref rid="ref106" ref-type="bibr">106</xref>].</p></sec><sec id="sec0060"><title>CONCLUSION</title><p>As a complex disorder involving multiple factors, PSP is challenging due to the inexplicit pathogenesis, lack of effective medications and poor prognosis. The genetic background of PSP has gained growing attention, and many data have suggested that genetics play a role in the susceptibility to PSP and that mutations of certain genes (such as <italic>MAPT)</italic> directly lead to PSP pathology. Faced with a series of risk factors and biological pathways associated with PSP, larger cohorts are required to validate these associations in addition to identify more novel loci. Functional studies are urgently needed to further elucidate underlying mechanisms, thus introducing new perspectives for diagnostic biomarkers and therapeutic targets for PSP and other tauopathies.</p></sec><sec sec-type="COI-statement" id="sec0065"><title>CONFLICT OF INTEREST</title><p>The authors have no conflict of interest to report.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This study was supported by the National Natural Science Foundation of China (No.&#x000a0;81671075, No.&#x000a0;81971029 and No.&#x000a0;81701134), the National Key R&#x00026;D Program of China (No.&#x000a0;2017YFC0840100 and 2017YFC0840104), the Provincial Key Plan for Research and Development of Hunan (No.&#x000a0;2017SK2031).</p></ack><ref-list><title>REFERENCES</title><ref id="ref001"><label>[1]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kawashima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kusumi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nakashima</surname>
<given-names>K</given-names>
</string-name> (<year>2004</year>) <article-title>Prevalence of progressive supranuclear palsy in Yonago, Japan</article-title>. <source>Mov Disord</source>
<volume>19</volume>, <fpage>1239</fpage>&#x02013;<lpage>1240</lpage>.<pub-id pub-id-type="pmid">15390010</pub-id></mixed-citation></ref><ref id="ref002"><label>[2]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>H&#x000f6;glinger</surname>
<given-names>GU</given-names>
</string-name> (<year>2017</year>) <article-title>Advances in progressive supranuclear palsy: New diagnostic criteria, biomarkers, and therapeutic approaches</article-title>. <source>Lancet Neurol</source>
<volume>16</volume>, <fpage>552</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">28653647</pub-id></mixed-citation></ref><ref id="ref003"><label>[3]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ling</surname>
<given-names>H</given-names>
</string-name> (<year>2016</year>) <article-title>Clinical approach to progressive supranuclear palsy</article-title>. <source>J Mov Disord</source>
<volume>9</volume>, <fpage>3</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">26828211</pub-id></mixed-citation></ref><ref id="ref004"><label>[4]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Armstrong</surname>
<given-names>MJ</given-names>
</string-name> (<year>2018</year>) <article-title>Progressive supranuclear palsy: An update</article-title>. <source>Curr Neurol Neurosci Rep</source>
<volume>18</volume>, <fpage>12</fpage>.<pub-id pub-id-type="pmid">29455271</pub-id></mixed-citation></ref><ref id="ref005"><label>[5]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Steele</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Olszewski</surname>
<given-names>J</given-names>
</string-name> (<year>1964</year>) <article-title>Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia</article-title>. <source>Arch Neurol</source>
<volume>10</volume>, <fpage>333</fpage>&#x02013;<lpage>359</lpage>.<pub-id pub-id-type="pmid">14107684</pub-id></mixed-citation></ref><ref id="ref006"><label>[6]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Agid</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dubois</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Duvoisin</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Goetz</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Grafman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Growdon</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Hallett</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jankovic</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Quinn</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zee</surname>
<given-names>DS</given-names>
</string-name> (<year>1996</year>) <article-title>Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop</article-title>. <source>Neurology</source>
<volume>47</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">8710059</pub-id></mixed-citation></ref><ref id="ref007"><label>[7]</label><mixed-citation publication-type="journal">
<string-name>
<surname>H&#x000f6;glinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Respondek</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Stamelou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kurz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Josephs</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Mollenhauer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Whitwell</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Englund</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gelpi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Giese</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Irwin</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Meissner</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Pantelyat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Troakes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Antonini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Bordelon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Compta</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Corvol</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Colosimo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Dodel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ferguson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Grossman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kassubek</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Krismer</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Levin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lorenzl</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Nestor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Oertel</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Poewe</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Rabinovici</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rowe</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Seppi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>van Eimeren</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wenning</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name> (<year>2017</year>) <article-title>Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria</article-title>. <source>Mov Disord</source>
<volume>32</volume>, <fpage>853</fpage>&#x02013;<lpage>864</lpage>.<pub-id pub-id-type="pmid">28467028</pub-id></mixed-citation></ref><ref id="ref008"><label>[8]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Botha</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ahlskog</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Bower</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Masumoto</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Maraganore</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hassan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Eggers</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Boeve</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>Knopman</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Drubach</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Dunkley</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>van Gerpen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Whitwell</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Josephs</surname>
<given-names>KA</given-names>
</string-name> (<year>2019</year>) <article-title>Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy</article-title>. <source>Mov Disord</source>
<volume>34</volume>, <fpage>1144</fpage>&#x02013;<lpage>1153</lpage>.<pub-id pub-id-type="pmid">30726566</pub-id></mixed-citation></ref><ref id="ref009"><label>[9]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hauw</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Daniel</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Horoupian</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Jellinger</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lantos</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>mckee</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tabaton</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name> (<year>1994</year>) <article-title>Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)</article-title>. <source>Neurology</source>
<volume>44</volume>, <fpage>2015</fpage>&#x02013;<lpage>2019</lpage>.<pub-id pub-id-type="pmid">7969952</pub-id></mixed-citation></ref><ref id="ref010"><label>[10]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hutton</surname>
<given-names>ML</given-names>
</string-name> (<year>2007</year>) <article-title>Progressive supranuclear palsy: Pathology and genetics</article-title>. <source>Brain Pathol</source>
<volume>17</volume>, <fpage>74</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">17493041</pub-id></mixed-citation></ref><ref id="ref011"><label>[11]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Williams</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Strand</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pittman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name> (<year>2007</year>) <article-title>Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson&#x02019;s syndrome</article-title>. <source>Brain</source>
<volume>130</volume>, <fpage>1566</fpage>&#x02013;<lpage>1576</lpage>.<pub-id pub-id-type="pmid">17525140</pub-id></mixed-citation></ref><ref id="ref012"><label>[12]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Williams</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name> (<year>2009</year>) <article-title>Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges</article-title>. <source>Lancet Neurol</source>
<volume>8</volume>, <fpage>270</fpage>&#x02013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">19233037</pub-id></mixed-citation></ref><ref id="ref013"><label>[13]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rojo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pernaute</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Font&#x000e1;n</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ru&#x000ed;z</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Honnorat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gonzalo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>R&#x000e1;bano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;nez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Daniel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pramstaller</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tabernero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nyggard</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Hanson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Y&#x000e9;benes</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Pramsteller</surname>
<given-names>P</given-names>
</string-name> (<year>1999</year>) <article-title>Clinical genetics of familial progressive supranuclear palsy</article-title>. <source>Brain</source>
<volume>122 (Pt 7)</volume>, <fpage>1233</fpage>&#x02013;<lpage>1245</lpage>.<pub-id pub-id-type="pmid">10388790</pub-id></mixed-citation></ref><ref id="ref014"><label>[14]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Fujioka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sanchez Contreras</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Strongosky</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Ogaki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Whaley</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Tacik</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>van Gerpen</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name> (<year>2015</year>) <article-title>Three sib-pairs of autopsy-confirmed progressive supranuclear palsy</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>21</volume>, <fpage>101</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">25443551</pub-id></mixed-citation></ref><ref id="ref015"><label>[15]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ros</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>G&#x000f3;mez Garre</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tai</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Ampuero</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Vidal</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rojo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fontan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vazquez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fanjul</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cantarero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hoenicka</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ahsan</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Pavese</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Piccini</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Perez-Tur</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nyggard</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>de Y&#x000e9;benes</surname>
<given-names>JG</given-names>
</string-name> (<year>2005</year>) <article-title>Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1</article-title>. <source>Ann Neurol</source>
<volume>57</volume>, <fpage>634</fpage>&#x02013;<lpage>641</lpage>.<pub-id pub-id-type="pmid">15852377</pub-id></mixed-citation></ref><ref id="ref016"><label>[16]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yabe</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Yaguchi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Miki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tanikawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shirai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsushima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujioka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kunieda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nishihara</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ohtsuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hatakeyama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wakabayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</string-name> (<year>2018</year>) <article-title>Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome</article-title>. <source>Sci Rep</source>
<volume>8</volume>, <fpage>819</fpage>.<pub-id pub-id-type="pmid">29339765</pub-id></mixed-citation></ref><ref id="ref017"><label>[17]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ygland</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>van Westen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Englund</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Landqvist Wald&#x000f6;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alafuzoff</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hansson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Gustafson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Puschmann</surname>
<given-names>A</given-names>
</string-name> (<year>2018</year>) <article-title>Slowly progressive dementia caused by MAPT R406W mutations: Longitudinal report on a new kindred and systematic review</article-title>. <source>Alzheimers Res Ther</source>
<volume>10</volume>, <fpage>2</fpage>.<pub-id pub-id-type="pmid">29370822</pub-id></mixed-citation></ref><ref id="ref018"><label>[18]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Donker Kaat</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Boon</surname>
<given-names>AJW</given-names>
</string-name>, <string-name>
<surname>Azmani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kamphorst</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Breteler</surname>
<given-names>MMB</given-names>
</string-name>, <string-name>
<surname>Anar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name> (<year>2009</year>) <article-title>Familial aggregation of parkinsonism in progressive supranuclear palsy</article-title>. <source>Neurology</source>
<volume>73</volume>, <fpage>98</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">19458322</pub-id></mixed-citation></ref><ref id="ref019"><label>[19]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Melhem</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Sleiman</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Klei</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Vandrovcova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hurtig</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Gross</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Maetzler</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Goldwurm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Borroni</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Pastor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cantwell</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Dillman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van der Brug</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Devlin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name> (<year>2011</year>) <article-title>Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy</article-title>. <source>Nat Genet</source>
<volume>43</volume>, <fpage>699</fpage>&#x02013;<lpage>705</lpage>.<pub-id pub-id-type="pmid">21685912</pub-id></mixed-citation></ref><ref id="ref020"><label>[20]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sanchez-Contreras</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Kouri</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Serie</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Heckman</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Finch</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Caselli</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Graff-Radford</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name> (<year>2018</year>) <article-title>Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci</article-title>. <source>Mol Neurodegener</source>
<volume>13</volume>, <fpage>37</fpage>.<pub-id pub-id-type="pmid">29986742</pub-id></mixed-citation></ref><ref id="ref021"><label>[21]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Won</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Wojta</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Bensimon</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Leigh</surname>
<given-names>PN</given-names>
</string-name>, <string-name>
<surname>Payan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shatunov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Deloukas</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Amouyel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tzourio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dartigues</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Ludolph</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Bronstein</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name> (<year>2018</year>) <article-title>Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases</article-title>. <source>Mol Neurodegener</source>
<volume>13</volume>, <fpage>41</fpage>.<pub-id pub-id-type="pmid">30089514</pub-id></mixed-citation></ref><ref id="ref022"><label>[22]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Shatunov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Kravitz</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Lawrence</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Payan</surname>
<given-names>CAM</given-names>
</string-name>, <string-name>
<surname>Lieb</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Franke</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Deloukas</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Amouyel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tzourio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dartigues</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Ludolph</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bensimon</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Leigh</surname>
<given-names>PN</given-names>
</string-name>, <string-name>
<surname>Bronstein</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</string-name> (<year>2019</year>) <article-title>Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy</article-title>. <source>Mov Disord</source>
<volume>34</volume>, <fpage>1049</fpage>&#x02013;<lpage>1059</lpage>.<pub-id pub-id-type="pmid">31059154</pub-id></mixed-citation></ref><ref id="ref023"><label>[23]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Spillantini</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Goedert</surname>
<given-names>M</given-names>
</string-name> (<year>2013</year>) <article-title>Tau pathology and neurodegeneration</article-title>. <source>Lancet Neurol</source>
<volume>12</volume>, <fpage>609</fpage>&#x02013;<lpage>622</lpage>.<pub-id pub-id-type="pmid">23684085</pub-id></mixed-citation></ref><ref id="ref024"><label>[24]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cruts</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Broeckhoven</surname>
<given-names>C</given-names>
</string-name> (<year>2004</year>) <article-title>The role of tau (MAPT) in frontotemporal dementia and related tauopathies</article-title>. <source>Hum Mutat</source>
<volume>24</volume>, <fpage>277</fpage>&#x02013;<lpage>295</lpage>.<pub-id pub-id-type="pmid">15365985</pub-id></mixed-citation></ref><ref id="ref025"><label>[25]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mandelkow</surname>
<given-names>E</given-names>
</string-name> (<year>2016</year>) <article-title>Tau in physiology and pathology</article-title>. <source>Nat Rev Neurosci</source>
<volume>17</volume>, <fpage>5</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">26631930</pub-id></mixed-citation></ref><ref id="ref026"><label>[26]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hutton</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lendon</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Rizzu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Froelich</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pickering-Brown</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chakraverty</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Isaacs</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Grover</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hackett</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Adamson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>de Graaff</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wauters</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>van Baren</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hillebrand</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Joosse</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Nowotny</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Che</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Norton</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Basun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lannfelt</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Neystat</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fahn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dark</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tannenberg</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dodd</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Hayward</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kwok</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Schofield</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Andreadis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Snowden</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Craufurd</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Neary</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Owen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Goate</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name> (<year>1998</year>) <article-title>Association of missense and 5&#x02019;-splice-site mutations in tau with the inherited dementia FTDP-17</article-title>. <source>Nature</source>
<volume>393</volume>, <fpage>702</fpage>&#x02013;<lpage>705</lpage>.<pub-id pub-id-type="pmid">9641683</pub-id></mixed-citation></ref><ref id="ref027"><label>[27]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Shafei</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Woollacott</surname>
<given-names>IOC</given-names>
</string-name>, <string-name>
<surname>Mummery</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Bocchetta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guerreiro</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bras</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Warren</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Lashley</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jaunmuktane</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Rohrer</surname>
<given-names>JD</given-names>
</string-name> (<year>2020</year>) <article-title>Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia</article-title>. <source>Neurobiol Aging</source>
<volume>87</volume>, <fpage>141.e115</fpage>&#x02013;<lpage>141.e120</lpage>.</mixed-citation></ref><ref id="ref028"><label>[28]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tagliavini</surname>
<given-names>F</given-names>
</string-name> (<year>2015</year>) <article-title>Frontotemporal lobar degeneration: Old knowledge and new insight into the pathogenetic mechanisms of tau mutations</article-title>. <source>Front Aging Neurosci</source>
<volume>7</volume>, <fpage>192</fpage>.<pub-id pub-id-type="pmid">26528178</pub-id></mixed-citation></ref><ref id="ref029"><label>[29]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Conrad</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Andreadis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wiederholt</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Masliah</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Thal</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Katzman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>T</given-names>
</string-name> (<year>1997</year>) <article-title>Genetic evidence for the involvement of tau in progressive supranuclear palsy</article-title>. <source>Ann Neurol</source>
<volume>41</volume>, <fpage>277</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="pmid">9029080</pub-id></mixed-citation></ref><ref id="ref030"><label>[30]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bennett</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bonifati</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Bonuccelli</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Colosimo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>De Mari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fabbrini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marconi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Meco</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nicholl</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Stocchi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vanacore</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vieregge</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>AC</given-names>
</string-name> (<year>1998</year>) <article-title>Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium</article-title>. <source>Neurology</source>
<volume>51</volume>, <fpage>982</fpage>&#x02013;<lpage>985</lpage>.<pub-id pub-id-type="pmid">9781517</pub-id></mixed-citation></ref><ref id="ref031"><label>[31]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Higgins</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Pho</surname>
<given-names>LT</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Nee</surname>
<given-names>LE</given-names>
</string-name> (<year>1998</year>) <article-title>Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene</article-title>. <source>Neurology</source>
<volume>50</volume>, <fpage>270</fpage>&#x02013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">9443491</pub-id></mixed-citation></ref><ref id="ref032"><label>[32]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Bandmann</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Daniel</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Rossor</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name> (<year>1999</year>) <article-title>The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<volume>66</volume>, <fpage>665</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="pmid">10209184</pub-id></mixed-citation></ref><ref id="ref033"><label>[33]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Baker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Adamson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Perez-Tur</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bigio</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hutton</surname>
<given-names>M</given-names>
</string-name> (<year>1999</year>) <article-title>Association of an extended haplotype in the tau gene with progressive supranuclear palsy</article-title>. <source>Hum Mol Genet</source>
<volume>8</volume>, <fpage>711</fpage>&#x02013;<lpage>715</lpage>.<pub-id pub-id-type="pmid">10072441</pub-id></mixed-citation></ref><ref id="ref034"><label>[34]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pastor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ezquerra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mu&#x000f1;oz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Valldeoriola</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Molinuevo</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Calopa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Oliva</surname>
<given-names>R</given-names>
</string-name> (<year>2002</year>) <article-title>Further extension of the H1 haplotype associated with progressive supranuclear palsy</article-title>. <source>Mov Disord</source>
<volume>17</volume>, <fpage>550</fpage>&#x02013;<lpage>556</lpage>.<pub-id pub-id-type="pmid">12112206</pub-id></mixed-citation></ref><ref id="ref035"><label>[35]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Melquist</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cruts</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Theuns</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Del-Favero</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Poorkaj</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sleegers</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Crook</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>De Pooter</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bel Kacem</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Adamson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Van den Bossche</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Van den Broeck</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gass</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Corsmit</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>De Rijk</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Engelborghs</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Heckman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Crook</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>De Deyn</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hutton</surname>
<given-names>ML</given-names>
</string-name> (<year>2005</year>) <article-title>High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy</article-title>. <source>Hum Mol Genet</source>
<volume>14</volume>, <fpage>3281</fpage>&#x02013;<lpage>3292</lpage>.<pub-id pub-id-type="pmid">16195395</pub-id></mixed-citation></ref><ref id="ref036"><label>[36]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pittman</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Myers</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Abou-Sleiman</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fung</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Kaleem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marlowe</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Duckworth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kilford</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name> (<year>2005</year>) <article-title>Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration</article-title>. <source>J Med Genet</source>
<volume>42</volume>, <fpage>837</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">15792962</pub-id></mixed-citation></ref><ref id="ref037"><label>[37]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Myers</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Kaleem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marlowe</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pittman</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Fung</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Duckworth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name> (<year>2005</year>) <article-title>The H1c haplotype at the MAPT locus is associated with Alzheimer&#x02019;s disease</article-title>. <source>Hum Mol Genet</source>
<volume>14</volume>, <fpage>2399</fpage>&#x02013;<lpage>2404</lpage>.<pub-id pub-id-type="pmid">16000317</pub-id></mixed-citation></ref><ref id="ref038"><label>[38]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Myers</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Pittman</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Rohrer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kaleem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marlowe</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>mckeith</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Perry</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Karlawish</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Arnold</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Forman</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Van Deerlin</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name> (<year>2007</year>) <article-title>The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts</article-title>. <source>Neurobiol Dis</source>
<volume>25</volume>, <fpage>561</fpage>&#x02013;<lpage>570</lpage>.<pub-id pub-id-type="pmid">17174556</pub-id></mixed-citation></ref><ref id="ref039"><label>[39]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Heckman</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Brennan</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Labb&#x000e9;</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Soto</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Koga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>deture</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Murray</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Boeve</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>van Gerpen</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name> (<year>2019</year>) <article-title>Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology</article-title>. <source>JAMA Neurol</source>
<volume>76</volume>, <fpage>710</fpage>&#x02013;<lpage>717</lpage>.<pub-id pub-id-type="pmid">30882841</pub-id></mixed-citation></ref><ref id="ref040"><label>[40]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Le Ber</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Camuzat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Guillot-Noel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hannequin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lacomblez</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Golfier</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Puel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Martinaud</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Deramecourt</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rivaud-Pechoux</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Millecamps</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vercelletto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Couratier</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Sellal</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pasquier</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Salachas</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Thomas-Ant&#x000e9;rion</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Didic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pariente</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Seilhean</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wargon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Blanc</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Camu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>B-F</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sauv&#x000e9;e</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Thauvin-Robinet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mondon</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tournier-Lasserve</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Goizet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fleury</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viennet</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Verpillat</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Meininger</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Duyckaerts</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dubois</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> (<year>2013</year>) <article-title>C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: A flow-chart for genetic testing</article-title>. <source>J Alzheimers Dis</source>
<volume>34</volume>, <fpage>485</fpage>&#x02013;<lpage>499</lpage>.<pub-id pub-id-type="pmid">23254636</pub-id></mixed-citation></ref><ref id="ref041"><label>[41]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Nakayama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimonaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Elahi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nishioka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Oji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>
<given-names>S-E</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yoshino</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mogushi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hatano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Motoi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name> (<year>2019</year>) <article-title>Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism</article-title>. <source>Neurobiol Aging</source>
<volume>84</volume>, <fpage>240.e213</fpage>&#x02013;<lpage>240.e222</lpage>.</mixed-citation></ref><ref id="ref042"><label>[42]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yasuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawamata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Komure</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Kuno</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>D&#x02019;Souza</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Poorkaj</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tanimukai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sasahara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hazama</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>C</given-names>
</string-name> (<year>1999</year>) <article-title>A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration</article-title>. <source>Neurology</source>
<volume>53</volume>, <fpage>864</fpage>&#x02013;<lpage>868</lpage>.<pub-id pub-id-type="pmid">10489057</pub-id></mixed-citation></ref><ref id="ref043"><label>[43]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ahmed</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Josephs</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>delledonne</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name> (<year>2008</year>) <article-title>Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy</article-title>. <source>Brain</source>
<volume>131</volume>, <fpage>460</fpage>&#x02013;<lpage>472</lpage>.<pub-id pub-id-type="pmid">18158316</pub-id></mixed-citation></ref><ref id="ref044"><label>[44]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gasparoli</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pasquali</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Di Fede</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Testa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Albanese</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bracco</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tagliavini</surname>
<given-names>F</given-names>
</string-name> (<year>2004</year>) <article-title>Progressive supranuclear palsy and Parkinson&#x02019;s disease in a family with a new mutation in the tau gene</article-title>. <source>Ann Neurol</source>
<volume>55</volume>, <fpage>448</fpage>.</mixed-citation></ref><ref id="ref045"><label>[45]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pastor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pastor</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Carnero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vela</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Amer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Oliva</surname>
<given-names>R</given-names>
</string-name> (<year>2001</year>) <article-title>Familial atypical progressive supranuclear palsy associated with homozigosity for the deln296 mutation in the tau gene</article-title>. <source>Ann Neurol</source>
<volume>49</volume>, <fpage>263</fpage>&#x02013;<lpage>267</lpage>.<pub-id pub-id-type="pmid">11220749</pub-id></mixed-citation></ref><ref id="ref046"><label>[46]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Poorkaj</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Muma</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Zhukareva</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cochran</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Shannon</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Hurtig</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Koller</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name> (<year>2002</year>) <article-title>An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype</article-title>. <source>Ann Neurol</source>
<volume>52</volume>, <fpage>511</fpage>&#x02013;<lpage>516</lpage>.<pub-id pub-id-type="pmid">12325083</pub-id></mixed-citation></ref><ref id="ref047"><label>[47]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Delisle</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Murrell</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Trofatter</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Rascol</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Soulages</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Mohr</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Calvas</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ghetti</surname>
<given-names>B</given-names>
</string-name> (<year>1999</year>) <article-title>A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy</article-title>. <source>Acta Neuropathol</source>
<volume>98</volume>, <fpage>62</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">10412802</pub-id></mixed-citation></ref><ref id="ref048"><label>[48]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Soliveri</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Monza</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tagliavini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Piacentini</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Albanese</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bugiani</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Girotti</surname>
<given-names>F</given-names>
</string-name> (<year>2003</year>) <article-title>A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene</article-title>. <source>Arch Neurol</source>
<volume>60</volume>, <fpage>1454</fpage>&#x02013;<lpage>1456</lpage>.<pub-id pub-id-type="pmid">14568818</pub-id></mixed-citation></ref><ref id="ref049"><label>[49]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ogaki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takanashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>K-I</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nonaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kishi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yoshino</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Funayama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tsukamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shioya</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yokochi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Imai</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kokubo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kuzuhara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Motoi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tomiyama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name> (<year>2013</year>) <article-title>Analyses of the MAPT, PGRN, and c9orf72 mutations in Japanese patients with FTLD, PSP, and CBS</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>19</volume>, <fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">22818528</pub-id></mixed-citation></ref><ref id="ref050"><label>[50]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ogaki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Motoi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tomiyama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Takanashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name> (<year>2011</year>) <article-title>Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): A comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy</article-title>. <source>Mov Disord</source>
<volume>26</volume>, <fpage>561</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">21462266</pub-id></mixed-citation></ref><ref id="ref051"><label>[51]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rohrer</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Paviour</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Vandrovcova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hodges</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rossor</surname>
<given-names>MN</given-names>
</string-name> (<year>2011</year>) <article-title>Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome</article-title>. <source>Neurodegener Dis</source>
<volume>8</volume>, <fpage>149</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">20838030</pub-id></mixed-citation></ref><ref id="ref052"><label>[52]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Nochlin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Poorkaj</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cherrier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kaye</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Payami</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Peskind</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lampe</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Nemens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name> (<year>1999</year>) <article-title>A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)</article-title>. <source>Brain</source>
<volume>122 (Pt 4)</volume>, <fpage>741</fpage>&#x02013;<lpage>756</lpage>.<pub-id pub-id-type="pmid">10219785</pub-id></mixed-citation></ref><ref id="ref053"><label>[53]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ros</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thobois</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Streichenberger</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kopp</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sanchez</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Perez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hoenicka</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Avila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Honnorat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Yebenes</surname>
<given-names>JG</given-names>
</string-name> (<year>2005</year>) <article-title>A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy</article-title>. <source>Arch Neurol</source>
<volume>62</volume>, <fpage>1444</fpage>&#x02013;<lpage>1450</lpage>.<pub-id pub-id-type="pmid">16157753</pub-id></mixed-citation></ref><ref id="ref054"><label>[54]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Stanford</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Halliday</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Kwok</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Storey</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Creasey</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Fulham</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Schofield</surname>
<given-names>PR</given-names>
</string-name> (<year>2000</year>) <article-title>Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations</article-title>. <source>Brain</source>
<volume>123 (Pt 5)</volume>, <fpage>880</fpage>&#x02013;<lpage>893</lpage>.<pub-id pub-id-type="pmid">10775534</pub-id></mixed-citation></ref><ref id="ref055"><label>[55]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Spina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Farlow</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Unverzagt</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Kareken</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Murrell</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Epperson</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Crowther</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Spillantini</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Goedert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ghetti</surname>
<given-names>B</given-names>
</string-name> (<year>2008</year>) <article-title>The tauopathy associated with mutation+3 in intron 10 of Tau: Characterization of the MSTD family</article-title>. <source>Brain</source>
<volume>131</volume>, <fpage>72</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">18065436</pub-id></mixed-citation></ref><ref id="ref056"><label>[56]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Omoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ikeuchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ogasawara</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Koga</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iwaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kanda</surname>
<given-names>T</given-names>
</string-name> (<year>2012</year>) <article-title>Autosomal dominant tauopathy with parkinsonism and central hypoventilation</article-title>. <source>Neurology</source>
<volume>78</volume>, <fpage>762</fpage>&#x02013;<lpage>764</lpage>.<pub-id pub-id-type="pmid">22357714</pub-id></mixed-citation></ref><ref id="ref057"><label>[57]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Osaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Quinn</surname>
<given-names>N</given-names>
</string-name> (<year>2003</year>) <article-title>Tau exon 10+16 mutation FTDP-17 presenting clinically as sporadic young onset PSP</article-title>. <source>Neurology</source>
<volume>61</volume>, <fpage>102</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">12847166</pub-id></mixed-citation></ref><ref id="ref058"><label>[58]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bastone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Piccoli</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Morbin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mazzoleni</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fugnanesi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Beeg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Del Favero</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cant&#x000f9;</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Motta</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Salsano</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pareyson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Erbetta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Elia</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Del Sorbo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Silani</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Morelli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Salmona</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tagliavini</surname>
<given-names>F</given-names>
</string-name> (<year>2014</year>) <article-title>Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>, <fpage>408</fpage>&#x02013;<lpage>417</lpage>.<pub-id pub-id-type="pmid">24018212</pub-id></mixed-citation></ref><ref id="ref059"><label>[59]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sanchez-Contreras</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Heckman</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Tacik</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Diehl</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Soto-Ortolaza</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Christopher</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Walton</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Graff-Radford</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name> (<year>2017</year>) <article-title>Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration</article-title>. <source>Mov Disord</source>
<volume>32</volume>, <fpage>115</fpage>&#x02013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">27709685</pub-id></mixed-citation></ref><ref id="ref060"><label>[60]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Deng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jankovic</surname>
<given-names>J</given-names>
</string-name> (<year>2018</year>) <article-title>The genetics of Parkinson disease</article-title>. <source>Ageing Res Rev</source>
<volume>42</volume>, <fpage>72</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">29288112</pub-id></mixed-citation></ref><ref id="ref061"><label>[61]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name> (<year>2017</year>) <article-title>Genetic analysis of R1628P in Parkinson&#x02019;s disease in Asian populations</article-title>. <source>Parkinsons Dis</source>
<volume>2017</volume>, <fpage>8093124</fpage>.<pub-id pub-id-type="pmid">29209554</pub-id></mixed-citation></ref><ref id="ref062"><label>[62]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Whittle</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Cobb</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Hulihan</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Toft</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name> (<year>2006</year>) <article-title>Lrrk2 R1441 substitution and progressive supranuclear palsy</article-title>. <source>Neuropathol Appl Neurobiol</source>
<volume>32</volume>, <fpage>23</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">16409550</pub-id></mixed-citation></ref><ref id="ref063"><label>[63]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Tan</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Skipper</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chua</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M-C</given-names>
</string-name>, <string-name>
<surname>Pavanni</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bonnard</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kolatkar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J-J</given-names>
</string-name> (<year>2006</year>) <article-title>Analysis of 14 LRRK2 mutations in Parkinson&#x02019;s plus syndromes and late-onset Parkinson&#x02019;s disease</article-title>. <source>Mov Disord</source>
<volume>21</volume>, <fpage>997</fpage>&#x02013;<lpage>1001</lpage>.<pub-id pub-id-type="pmid">16602113</pub-id></mixed-citation></ref><ref id="ref064"><label>[64]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gaig</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ezquerra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Valldeoriola</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mu&#x000f1;oz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Llad&#x000f3;</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rey</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Cardozo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Molinuevo</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name> (<year>2008</year>) <article-title>Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration</article-title>. <source>J Neurol Sci</source>
<volume>270</volume>, <fpage>94</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">18353371</pub-id></mixed-citation></ref><ref id="ref065"><label>[65]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Madzar</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schulte</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name> (<year>2009</year>) <article-title>Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany</article-title>. <source>Eur J Neurol</source>
<volume>16</volume>, <fpage>1230</fpage>&#x02013;<lpage>1232</lpage>.<pub-id pub-id-type="pmid">19538213</pub-id></mixed-citation></ref><ref id="ref066"><label>[66]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Biskup</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Leitner</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lichtner</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kachergus</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hulihan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Stoessl</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Pfeiffer</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Patenge</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Carbajal</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Vieregge</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Asmus</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller-Myhsok</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Meitinger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Strom</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name> (<year>2004</year>) <article-title>Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</article-title>. <source>Neuron</source>
<volume>44</volume>, <fpage>601</fpage>&#x02013;<lpage>607</lpage>.<pub-id pub-id-type="pmid">15541309</pub-id></mixed-citation></ref><ref id="ref067"><label>[67]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Spanaki</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Latsoudis</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Plaitakis</surname>
<given-names>A</given-names>
</string-name> (<year>2006</year>) <article-title>LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP</article-title>. <source>Neurology</source>
<volume>67</volume>, <fpage>1518</fpage>&#x02013;<lpage>1519</lpage>.<pub-id pub-id-type="pmid">17060595</pub-id></mixed-citation></ref><ref id="ref068"><label>[68]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rajput</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>D&#x000e4;chsel</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Cobb</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name> (<year>2006</year>) <article-title>Parkinsonism, Lrrk2 G2019S, and tau neuropathology</article-title>. <source>Neurology</source>
<volume>67</volume>, <fpage>1506</fpage>&#x02013;<lpage>1508</lpage>.<pub-id pub-id-type="pmid">17060589</pub-id></mixed-citation></ref><ref id="ref069"><label>[69]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ruffmann</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Giaccone</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Canesi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bramerio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goldwurm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gambacorta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tagliavini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pezzoli</surname>
<given-names>G</given-names>
</string-name> (<year>2012</year>) <article-title>Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism</article-title>. <source>Neuropathol Appl Neurobiol</source>
<volume>38</volume>, <fpage>382</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">21883375</pub-id></mixed-citation></ref><ref id="ref070"><label>[70]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Blauwendraat</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pletnikova</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Geiger</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Abramzon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Rudow</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mamais</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sabir</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Crain</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rosenthal</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Bakker</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Faghri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chia</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Pantelyat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Albert</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Nalls</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Resnick</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Ferrucci</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Hillis</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Troncoso</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Scholz</surname>
<given-names>SW</given-names>
</string-name> (<year>2019</year>) <article-title>Genetic analysis of neurodegenerative diseases in a pathology cohort</article-title>. <source>Neurobiol Aging</source>
<volume>76</volume>, <fpage>214.e211</fpage>&#x02013;<lpage>214.e219</lpage>.</mixed-citation></ref><ref id="ref071"><label>[71]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Greggio</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name> (<year>2009</year>) <article-title>Leucine-rich repeat kinase 2 mutations and Parkinson&#x02019;s disease: Three questions</article-title>. <source>ASN Neuro</source>
<volume>1</volume>, <fpage>e00002</fpage>.<pub-id pub-id-type="pmid">19570025</pub-id></mixed-citation></ref><ref id="ref072"><label>[72]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Trinh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guella</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>mckenzie</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gustavsson</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Szu-Tu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>mckeown</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Aasly</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Bardien</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name> (<year>2015</year>) <article-title>Novel LRRK2 mutations in Parkinsonism</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>21</volume>, <fpage>1119</fpage>&#x02013;<lpage>1121</lpage>.<pub-id pub-id-type="pmid">26213354</pub-id></mixed-citation></ref><ref id="ref073"><label>[73]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Pfeiffer</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>mccomb</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Stoessl</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Strongosky</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller-Myhsok</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name> (<year>2004</year>) <article-title>Autosomal dominant parkinsonism associated with variable synuclein and tau pathology</article-title>. <source>Neurology</source>
<volume>62</volume>, <fpage>1619</fpage>&#x02013;<lpage>1622</lpage>.<pub-id pub-id-type="pmid">15136696</pub-id></mixed-citation></ref><ref id="ref074"><label>[74]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Schroer</surname>
<given-names>TA</given-names>
</string-name> (<year>2004</year>) <article-title>Dynactin</article-title>. <source>Annu Rev Cell Dev Biol</source>
<volume>20</volume>, <fpage>759</fpage>&#x02013;<lpage>779</lpage>.<pub-id pub-id-type="pmid">15473859</pub-id></mixed-citation></ref><ref id="ref075"><label>[75]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Puls</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Jonnakuty</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>lamonte</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Holzbaur</surname>
<given-names>ELF</given-names>
</string-name>, <string-name>
<surname>Tokito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Floeter</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Bidus</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Drayna</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Ludlow</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Fischbeck</surname>
<given-names>KH</given-names>
</string-name> (<year>2003</year>) <article-title>Mutant dynactin in motor neuron disease</article-title>. <source>Nat Genet</source>
<volume>33</volume>, <fpage>455</fpage>&#x02013;<lpage>456</lpage>.<pub-id pub-id-type="pmid">12627231</pub-id></mixed-citation></ref><ref id="ref076"><label>[76]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Hulihan</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Kachergus</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>D&#x000e4;chsel</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Stoessl</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Grantier</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Lechevalier</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chapon</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gutmann</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Elibol</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Wider</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Castanedes-Casey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name> (<year>2009</year>) <article-title>DCTN1 mutations in Perry syndrome</article-title>. <source>Nat Genet</source>
<volume>41</volume>, <fpage>163</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">19136952</pub-id></mixed-citation></ref><ref id="ref077"><label>[77]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Konno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Teive</surname>
<given-names>HAG</given-names>
</string-name>, <string-name>
<surname>S&#x00142;awek</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name> (<year>2017</year>) <article-title>DCTN1-related neurodegeneration: Perry syndrome and beyond</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>41</volume>, <fpage>14</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">28625595</pub-id></mixed-citation></ref><ref id="ref078"><label>[78]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Caroppo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Le Ber</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Clot</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Rivaud-P&#x000e9;choux</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Camuzat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>De Septenville</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Boutoleau-Bretonni&#x000e8;re</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mourlon</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sauv&#x000e9;e</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lebouvier</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bonnet</surname>
<given-names>A-M</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vercelletto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> (<year>2014</year>) <article-title>DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes</article-title>. <source>JAMA Neurol</source>
<volume>71</volume>, <fpage>208</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">24343258</pub-id></mixed-citation></ref><ref id="ref079"><label>[79]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gustavsson</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Trinh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guella</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Szu-Tu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Khinda</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Stoessl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>mckeown</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Aasly</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name> (<year>2016</year>) <article-title>DCTN1 p.K56R in progressive supranuclear palsy</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>28</volume>, <fpage>56</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">27132499</pub-id></mixed-citation></ref><ref id="ref080"><label>[80]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Honda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sasagasako</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shijo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hamasaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>SO</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Iwaki</surname>
<given-names>T</given-names>
</string-name> (<year>2018</year>) <article-title>DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>51</volume>, <fpage>105</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">29499916</pub-id></mixed-citation></ref><ref id="ref081"><label>[81]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Godeiro-Junior</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Inaoka</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Barbosa</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Aguiar Pde</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Barsottini</surname>
<given-names>O</given-names>
</string-name> (<year>2006</year>) <article-title>Mutations in NPC1 in two Brazilian patients with Niemann-Pick disease type C and progressive supranuclear palsy-like presentation</article-title>. <source>Mov Disord</source>
<volume>21</volume>, <fpage>2270</fpage>&#x02013;<lpage>2272</lpage>.<pub-id pub-id-type="pmid">17044092</pub-id></mixed-citation></ref><ref id="ref082"><label>[82]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Cupidi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Frangipane</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gallo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Clodomiro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Colao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bernardi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Anfossi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Conidi</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Vasso</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Curcio</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Mirabelli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Smirne</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Torchia</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Muraca</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Puccio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Di Lorenzo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zampieri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Romanello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dardis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Maletta</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Bruni</surname>
<given-names>AC</given-names>
</string-name> (<year>2017</year>) <article-title>Role of Niemann-Pick Type C disease mutations in dementia</article-title>. <source>J Alzheimers Dis</source>
<volume>55</volume>, <fpage>1249</fpage>&#x02013;<lpage>1259</lpage>.<pub-id pub-id-type="pmid">27792009</pub-id></mixed-citation></ref><ref id="ref083"><label>[83]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Lesage</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Le Ber</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Condroyer</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Broussolle</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gabelle</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thobois</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pasquier</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mondon</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dion</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Rochefort</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>D&#x000fc;rr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> (<year>2013</year>) <article-title>c9orf72 repeat expansions are a rare genetic cause of parkinsonism</article-title>. <source>Brain</source>
<volume>136</volume>, <fpage>385</fpage>&#x02013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">23413259</pub-id></mixed-citation></ref><ref id="ref084"><label>[84]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Morales</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;nez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gonzalo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Vidal</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ros</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gomez-Tortosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rabano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ampuero</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>S&#x000e1;nchez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hoenicka</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Garc&#x000ed;a De Y&#x000e9;benes</surname>
<given-names>J</given-names>
</string-name> (<year>2002</year>) <article-title>Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein</article-title>. <source>Mov Disord</source>
<volume>17</volume>, <fpage>1374</fpage>&#x02013;<lpage>1380</lpage>.<pub-id pub-id-type="pmid">12465088</pub-id></mixed-citation></ref><ref id="ref085"><label>[85]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sanchez</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Gonzalo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Avila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>De Yebenes</surname>
<given-names>JG</given-names>
</string-name> (<year>2002</year>) <article-title>Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation</article-title>. <source>J Alzheimers Dis</source>
<volume>4</volume>, <fpage>399</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="pmid">12446971</pub-id></mixed-citation></ref><ref id="ref086"><label>[86]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ros</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ampuero</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Garc&#x000ed;a de Y&#x000e9;benes</surname>
<given-names>J</given-names>
</string-name> (<year>2008</year>) <article-title>Parkin polymorphisms in progressive supranuclear palsy</article-title>. <source>J Neurol Sci</source>
<volume>268</volume>, <fpage>176</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">18022644</pub-id></mixed-citation></ref><ref id="ref087"><label>[87]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Cannas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Borghero</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Floris</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Solla</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chi&#x000f2;</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Calvo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Restagno</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Majounie</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Costantino</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Piras</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lavra</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pani</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Orofino</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Di Stefano</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tacconi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mascia</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Muroni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Murru</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Tranquilli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Corongiu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rolesu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cuccu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marrosu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Marrosu</surname>
<given-names>MG</given-names>
</string-name> (<year>2013</year>) <article-title>The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson&#x02019;s disease and other degenerative parkinsonisms</article-title>. <source>Neurogenetics</source>
<volume>14</volume>, <fpage>161</fpage>&#x02013;<lpage>166</lpage>.<pub-id pub-id-type="pmid">23546887</pub-id></mixed-citation></ref><ref id="ref088"><label>[88]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yabe</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Nakano</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shirai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsushima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</string-name> (<year>2016</year>) <article-title>Frontotemporal dementia and progressive supranuclear palsy-like syndrome with a novel TARDBP mutation</article-title>. <source>Neurol Clin Neurosc</source>
<volume>4</volume>, <fpage>76</fpage>&#x02013;<lpage>77</lpage>.</mixed-citation></ref><ref id="ref089"><label>[89]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Tremolizzo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bertola</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Casati</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Piperno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ferrarese</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Appollonio</surname>
<given-names>I</given-names>
</string-name> (<year>2011</year>) <article-title>Progressive supranuclear palsy-like phenotype caused by progranulin p.Thr272fs mutation</article-title>. <source>Mov Disord</source>
<volume>26</volume>, <fpage>1964</fpage>&#x02013;<lpage>1966</lpage>.<pub-id pub-id-type="pmid">21542024</pub-id></mixed-citation></ref><ref id="ref090"><label>[90]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wilke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baets</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>De Bleecker</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Deconinck</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Biskup</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hayer</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Zuchner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Synofzik</surname>
<given-names>M</given-names>
</string-name> (<year>2018</year>) <article-title>Beyond ALS and FTD: The phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes</article-title>. <source>Neurobiol Aging</source>
<volume>62</volume>, <fpage>244.e249</fpage>&#x02013;<lpage>244.e213</lpage>.</mixed-citation></ref><ref id="ref091"><label>[91]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Tang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name> (<year>2016</year>) <article-title>Analyses MAPT, GRN, and c9orf72 mutations in Chinese patients with frontotemporal dementia</article-title>. <source>Neurobiol Aging</source>
<volume>46</volume>, <fpage>235.e211</fpage>&#x02013;<lpage>235.e215</lpage>.</mixed-citation></ref><ref id="ref092"><label>[92]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>B</given-names>
</string-name> (<year>2018</year>) <article-title>Integrated genetic analysis of racial differences of common variants in Parkinson&#x02019;s disease: A meta-analysis</article-title>. <source>Front Mol Neurosci</source>
<volume>11</volume>, <fpage>43</fpage>.<pub-id pub-id-type="pmid">29527153</pub-id></mixed-citation></ref><ref id="ref093"><label>[93]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jiao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name> (<year>2018</year>) <article-title>Rare variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort</article-title>. <source>Transl Neurodegener</source>
<volume>7</volume>, <fpage>31</fpage>.<pub-id pub-id-type="pmid">30534373</pub-id></mixed-citation></ref><ref id="ref094"><label>[94]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jiao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name> (<year>2014</year>) <article-title>Identification of c9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>, <fpage>936.e919</fpage>&#x02013;<lpage>936.e922</lpage>.</mixed-citation></ref><ref id="ref095"><label>[95]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Stamelou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Quinn</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</string-name> (<year>2013</year>) <article-title>&#x0201c;Atypical&#x0201d; atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide</article-title>. <source>Mov Disord</source>
<volume>28</volume>, <fpage>1184</fpage>&#x02013;<lpage>1199</lpage>.<pub-id pub-id-type="pmid">23720239</pub-id></mixed-citation></ref><ref id="ref096"><label>[96]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wilke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pomper</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Biskup</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Puskas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Synofzik</surname>
<given-names>M</given-names>
</string-name> (<year>2016</year>) <article-title>Atypical parkinsonism in c9orf72 expansions: A case report and systematic review of 45 cases from the literature</article-title>. <source>J Neurol</source>
<volume>263</volume>, <fpage>558</fpage>&#x02013;<lpage>574</lpage>.<pub-id pub-id-type="pmid">26810719</pub-id></mixed-citation></ref><ref id="ref097"><label>[97]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Melquist</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Craig</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Huentelman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Crook</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zismann</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Gass</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Adamson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Szelinger</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Corneveaux</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cannon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Coon</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tuite</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Calne</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Bigio</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Caselli</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Graff-Radford</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Litvan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Hutton</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stephan</surname>
<given-names>DA</given-names>
</string-name> (<year>2007</year>) <article-title>Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms</article-title>. <source>Am J Hum Genet</source>
<volume>80</volume>, <fpage>769</fpage>&#x02013;<lpage>778</lpage>.<pub-id pub-id-type="pmid">17357082</pub-id></mixed-citation></ref><ref id="ref098"><label>[98]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>Q</given-names>
</string-name> (<year>2015</year>) <article-title>Genetic study of complex diseases in the post-GWAS era</article-title>. <source>J Genet Genomics</source>
<volume>42</volume>, <fpage>87</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">25819085</pub-id></mixed-citation></ref><ref id="ref099"><label>[99]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Klein</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Zeiss</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chew</surname>
<given-names>EY</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>J-Y</given-names>
</string-name>, <string-name>
<surname>Sackler</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Haynes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Henning</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>sangiovanni</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Mane</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mayne</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Bracken</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Ferris</surname>
<given-names>FL</given-names>
</string-name>, <string-name>
<surname>Ott</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Barnstable</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hoh</surname>
<given-names>J</given-names>
</string-name> (<year>2005</year>) <article-title>Complement factor H polymorphism in age-related macular degeneration</article-title>. <source>Science</source>
<volume>308</volume>, <fpage>385</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">15761122</pub-id></mixed-citation></ref><ref id="ref100"><label>[100]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Manolio</surname>
<given-names>TA</given-names>
</string-name> (<year>2013</year>) <article-title>Bringing genome-wide association findings into clinical use</article-title>. <source>Nat Rev Genet</source>
<volume>14</volume>, <fpage>549</fpage>&#x02013;<lpage>558</lpage>.<pub-id pub-id-type="pmid">23835440</pub-id></mixed-citation></ref><ref id="ref101"><label>[101]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ferrari</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ryten</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Simone</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Trabzuni</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nicolaou</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hondhamuni</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ramasamy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vandrovcova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Weale</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Momeni</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name> (<year>2014</year>) <article-title>Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>, 1514.e<fpage>1511</fpage>&#x02013;<lpage>1512</lpage>.<pub-id pub-id-type="pmid">24439478</pub-id></mixed-citation></ref><ref id="ref102"><label>[102]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ron</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Walter</surname>
<given-names>P</given-names>
</string-name> (<year>2007</year>) <article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title>. <source>Nat Rev Mol Cell Biol</source>
<volume>8</volume>, <fpage>519</fpage>&#x02013;<lpage>529</lpage>.<pub-id pub-id-type="pmid">17565364</pub-id></mixed-citation></ref><ref id="ref103"><label>[103]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Stutzbach</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>SX</given-names>
</string-name>, <string-name>
<surname>Naj</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Albin</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gilman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>VMY</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Devlin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name> (<year>2013</year>) <article-title>The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer&#x02019;s disease</article-title>. <source>Acta Neuropathol Commun</source>
<volume>1</volume>, <fpage>31</fpage>.<pub-id pub-id-type="pmid">24252572</pub-id></mixed-citation></ref><ref id="ref104"><label>[104]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bruch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kurz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vasiljevic</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nicolino</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>H&#x000f6;glinger</surname>
<given-names>GU</given-names>
</string-name> (<year>2015</year>) <article-title>Early neurodegeneration in the brain of a child without functional PKR-like endoplasmic reticulum kinase</article-title>. <source>J Neuropathol Exp Neurol</source>
<volume>74</volume>, <fpage>850</fpage>&#x02013;<lpage>857</lpage>.<pub-id pub-id-type="pmid">26172286</pub-id></mixed-citation></ref><ref id="ref105"><label>[105]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tseng</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Heyser</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Rockenstein</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mante</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Adame</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Arslan</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Chakrabarty</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mobley</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y-W</given-names>
</string-name>, <string-name>
<surname>St George-Hyslop</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Masliah</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name> (<year>2015</year>) <article-title>Appoptosin-mediated caspase cleavage of tau contributes to progressive supranuclear palsy pathogenesis</article-title>. <source>Neuron</source>
<volume>87</volume>, <fpage>963</fpage>&#x02013;<lpage>975</lpage>.<pub-id pub-id-type="pmid">26335643</pub-id></mixed-citation></ref><ref id="ref106"><label>[106]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jabbari</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Woodside</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>MMX</given-names>
</string-name>, <string-name>
<surname>Shoai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pittman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ferrari</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mok</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Reynolds</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Grimm</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Respondek</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Al-Sarraj</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gentleman</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Warner</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Ryten</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name> (<year>2018</year>) <article-title>Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype</article-title>. <source>Ann Neurol</source>
<volume>84</volume>, <fpage>485</fpage>&#x02013;<lpage>496</lpage>.<pub-id pub-id-type="pmid">30066433</pub-id></mixed-citation></ref><ref id="ref107"><label>[107]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Brewer</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name> (<year>2017</year>) <article-title>Enhanced degradation of misfolded proteins promotes tumorigenesis</article-title>. <source>Cell Rep</source>
<volume>18</volume>, <fpage>3143</fpage>&#x02013;<lpage>3154</lpage>.<pub-id pub-id-type="pmid">28355566</pub-id></mixed-citation></ref></ref-list></back></article>